Please use this identifier to cite or link to this item:
|Title:||Somatostatin receptors in nasopharyngeal carcinoma||Authors:||Loh, K.S.
|Issue Date:||2002||Citation:||Loh, K.S., Waser, B., Tan, L.K.S., Ruan, R.S., Stauffer, E., Reubi, J.C. (2002). Somatostatin receptors in nasopharyngeal carcinoma. Virchows Archiv 441 (5) : 444-448. ScholarBank@NUS Repository. https://doi.org/10.1007/s00428-002-0693-y||Abstract:||Somatostatin receptors (SS-Rs) are expressed in neuroendocrine tumour tissues where they can be targetted for diagnosis and therapy. This study investigated the presence of SS-Rs in nasopharyngeal carcinoma (NPC), a common cancer in South-East Asia. Nasopharynx biopsy specimens were obtained from 12 NPC patients and 5 patients without tumours. Somatostatin receptor autoradiography was performed using 125I-labelled [Tyr3]-octreotide and 125I-labelled [Leu8, DTrp22, Tyr25]-somatostatin-28 as radioligands. Of the 12 NPC samples 9 showed moderate to high expression of SS-Rs. These were of the sst2 type, based on the rank order of potency of subtype-selective analogues. The 5 non-neoplastic samples, consisting primarily of granulomatous tissue, did not express measurable amounts of SS-Rs. This study demonstrates for the first time the presence of type 2 SS-R in NPC. These receptors may play a role in the management of NPC, as is the case for other somatostatin-expressing tumours.||Source Title:||Virchows Archiv||URI:||http://scholarbank.nus.edu.sg/handle/10635/130373||ISSN:||09456317||DOI:||10.1007/s00428-002-0693-y|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.